827 related articles for article (PubMed ID: 11489748)
1. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.
Khuri FR; Kim ES; Lee JJ; Winn RJ; Benner SE; Lippman SM; Fu KK; Cooper JS; Vokes EE; Chamberlain RM; Williams B; Pajak TF; Goepfert H; Hong WK
Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):823-9. PubMed ID: 11489748
[TBL] [Abstract][Full Text] [Related]
2. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
Khuri FR; Lee JJ; Lippman SM; Kim ES; Cooper JS; Benner SE; Winn R; Pajak TF; Williams B; Shenouda G; Hodson I; Fu K; Shin DM; Vokes EE; Feng L; Goepfert H; Hong WK
J Natl Cancer Inst; 2006 Apr; 98(7):441-50. PubMed ID: 16595780
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of second head and neck tumors in primary laryngeal SCC is an indicator of overall survival and not associated with poorer overall survival: a single centre study in 987 patients.
Farhadieh RD; Salardini A; Yang JL; Russell P; Smee R
J Surg Oncol; 2010 Jan; 101(1):72-7. PubMed ID: 19798688
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.
Minard CG; Spitz MR; Wu X; Hong WK; Etzel CJ
Cancer; 2006 Jun; 106(12):2636-44. PubMed ID: 16703596
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of head and neck cancer with retinoids: a negative result.
Perry CF; Stevens M; Rabie I; Yarker ME; Cochrane J; Perry E; Traficante R; Coman W
Arch Otolaryngol Head Neck Surg; 2005 Mar; 131(3):198-203. PubMed ID: 15781758
[TBL] [Abstract][Full Text] [Related]
6. The relation between cancer incidence among relatives and the occurrence of multiple primary carcinomas following head and neck cancer.
Bongers V; Braakhuis BJ; Tobi H; Lubsen H; Snow GB
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):595-8. PubMed ID: 8824360
[TBL] [Abstract][Full Text] [Related]
7. Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.
Rosenquist K
Swed Dent J Suppl; 2005; (179):1-66. PubMed ID: 16335030
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients.
Bairati I; Meyer F; Gélinas M; Fortin A; Nabid A; Brochet F; Mercier JP; Têtu B; Harel F; Mâsse B; Vigneault E; Vass S; del Vecchio P; Roy J
J Natl Cancer Inst; 2005 Apr; 97(7):481-8. PubMed ID: 15812073
[TBL] [Abstract][Full Text] [Related]
9. Local recurrences and second primary tumors from squamous cell carcinoma of the oral cavity: a retrospective analytic study of 500 patients.
González-García R; Naval-Gías L; Román-Romero L; Sastre-Pérez J; Rodríguez-Campo FJ
Head Neck; 2009 Sep; 31(9):1168-80. PubMed ID: 19408289
[TBL] [Abstract][Full Text] [Related]
10. Randomized trial of supplemental beta-carotene to prevent second head and neck cancer.
Mayne ST; Cartmel B; Baum M; Shor-Posner G; Fallon BG; Briskin K; Bean J; Zheng T; Cooper D; Friedman C; Goodwin WJ
Cancer Res; 2001 Feb; 61(4):1457-63. PubMed ID: 11245451
[TBL] [Abstract][Full Text] [Related]
11. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck.
Hong WK; Lippman SM; Itri LM; Karp DD; Lee JS; Byers RM; Schantz SP; Kramer AM; Lotan R; Peters LJ
N Engl J Med; 1990 Sep; 323(12):795-801. PubMed ID: 2202902
[TBL] [Abstract][Full Text] [Related]
12. Second primary head and neck squamous cell carcinoma predicted by the glutathione S-transferase expression in healthy tissue in the direct vicinity of the first tumor.
Bongers V; Snow GB; de Vries N; Cattan AR; Hall AG; van der Waal I; Braakhuis BJ
Lab Invest; 1995 Oct; 73(4):503-10. PubMed ID: 7474922
[TBL] [Abstract][Full Text] [Related]
13. Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590).
Bhatia AK; Lee JW; Pinto HA; Jacobs CD; Limburg PJ; Rubin P; Arusell RM; Dunphy EP; Khandekar JD; Reiner SA; Baez-Diaz L; Celano P; Li S; Li Y; Burtness BA; Adams GL; Pandya KJ
Cancer; 2017 Dec; 123(23):4653-4662. PubMed ID: 28786105
[TBL] [Abstract][Full Text] [Related]
14. Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer.
Lippman SM; Lee JJ; Karp DD; Vokes EE; Benner SE; Goodman GE; Khuri FR; Marks R; Winn RJ; Fry W; Graziano SL; Gandara DR; Okawara G; Woodhouse CL; Williams B; Perez C; Kim HW; Lotan R; Roth JA; Hong WK
J Natl Cancer Inst; 2001 Apr; 93(8):605-18. PubMed ID: 11309437
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy in larynx squamous cell carcinoma is not associated with an increased diagnosis of second primary tumours.
Farhadieh RD; Rees CG; Yang JL; Salardini A; Russell P; Smee R
Clin Oncol (R Coll Radiol); 2009 May; 21(4):315-9. PubMed ID: 19233627
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for developing a second upper aerodigestive cancer after radiotherapy with or without chemotherapy in patients with head-and-neck cancers: an exploratory outcomes analysis.
Taussky D; Rufibach K; Huguenin P; Allal AS
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):684-9. PubMed ID: 15936546
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for the development of second primary tumors among men after laryngeal and hypopharyngeal carcinoma.
Dikshit RP; Boffetta P; Bouchardy C; Merletti F; Crosignani P; Cuchi T; Ardanaz E; Brennan P
Cancer; 2005 Jun; 103(11):2326-33. PubMed ID: 15852357
[TBL] [Abstract][Full Text] [Related]
18. The risk of second primary tumors in patients with nasopharyngeal carcinoma after definitive radiotherapy.
Kong L; Lu JJ; Hu C; Guo X; Wu Y; Zhang Y
Cancer; 2006 Sep; 107(6):1287-93. PubMed ID: 16909425
[TBL] [Abstract][Full Text] [Related]
19. Retinoid chemoprevention of second primary tumors.
Benner SE; Lippman SM; Hong WK
Semin Hematol; 1994 Oct; 31(4 Suppl 5):26-30. PubMed ID: 7831582
[TBL] [Abstract][Full Text] [Related]
20. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
